Literature DB >> 8370168

C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells.

S Sacks1, W Zhou, R D Campbell, J Martin.   

Abstract

The glomerular mesangial cell (GMC) plays a key role in the maintenance of glomerular structure and function and in the mediation of glomerular injury. To explore the potential of this cell to produce complement and react to local inflammatory signals, we studied the synthesis and regulation of the third and fourth components of complement in cultured human GMC. Using metabolic labelling and immunoprecipitation, we found that C3 and C4 polypeptide chains were synthesized and secreted by GMC. Interferon-gamma (IFN-gamma) led to an increase in C4 protein synthesis, but not C3 synthesis. There was a corresponding increase in C4 mRNA in IFN-gamma-activated cells, but no increase in C3 mRNA, as determined by semi-quantitative polymerase chain reaction (PCR) estimation. These results demonstrate that human GMC can synthesize C3 and C4 proteins, and that regulation of expression of the C4 gene is mediated by IFN-gamma. We hypothesize that GMC production of complement could influence the clearance of immune aggregates by the kidney and the mediation of glomerular injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370168      PMCID: PMC1554924          DOI: 10.1111/j.1365-2249.1993.tb08193.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells.

Authors:  J Chelly; D Montarras; C Pinset; Y Berwald-Netter; J C Kaplan; A Kahn
Journal:  Eur J Biochem       Date:  1990-02-14

2.  Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes.

Authors:  J Kulics; H R Colten; D H Perlmutter
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 3.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

4.  Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues.

Authors:  S Ruddy; H R Colten
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide.

Authors:  R C Strunk; A S Whitehead; F S Cole
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9.

Authors:  M Schönermark; R Deppisch; G Riedasch; K Rother; G M Hänsch
Journal:  Int Arch Allergy Appl Immunol       Date:  1991

8.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

9.  Identification and structural characterization of two incompletely processed forms of the fourth component of human complement.

Authors:  A C Chan; J P Atkinson
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and for gene conversion at the C4B locus.

Authors:  L Braun; P M Schneider; C M Giles; J Bertrams; C Rittner
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  16 in total

Review 1.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

2.  Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction.

Authors:  G Gruden; S Thomas; D Burt; S Lane; G Chusney; S Sacks; G Viberti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.

Authors:  M C Pickering; J Warren; K L Rose; F Carlucci; Y Wang; M J Walport; H T Cook; M Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

4.  Intraglomerular C3 synthesis in rats with passive Heymann nephritis.

Authors:  O Sasaki; W Zhou; M Miyazaki; K Abe; T Koji; P Verroust; S Tsukasaki; Y Ozono; T Harada; P K Nakane; S Kohno; S H Sacks
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 5.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 6.  Post-bone marrow transplant thrombotic microangiopathy.

Authors:  F Obut; V Kasinath; R Abdi
Journal:  Bone Marrow Transplant       Date:  2016-03-14       Impact factor: 5.483

Review 7.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

8.  Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome.

Authors:  Bristol Sorensen; James F Jones; Suzanne D Vernon; Mangalathu S Rajeevan
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

Review 9.  Allograft rejection: effect of local synthesis of complement.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

10.  Which pathways trigger the role of complement in ischaemia/reperfusion injury?

Authors:  Conrad A Farrar; Elham Asgari; Wilhelm J Schwaeble; Steven H Sacks
Journal:  Front Immunol       Date:  2012-11-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.